RxDoctor Payments Data

Francis Benn, MD

Clinical Cardiac Electrophysiology · Birmingham, ALNPI 1972842201

Payments from drug & device makers

What this record shows

This record is dominated by grants: $64,827 of the $95,080 with a category attached, or 68.2%. 23 manufacturers reported payments, led by Abbott at 44.8% of the total. Reporting peaked in 2021 at $41,672 and has fallen 79.2% since, to $8,685 in 2025. Among clinical cardiac electrophysiology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,080in general payments, 2019–2025

Across 289 payments — averaging $329.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$43K
  • Medtronic$33K
  • Biosense Webster, Inc.$9K
  • Biotronik Inc.$5K
  • Boston Scientific$3K
  • Medical Device Business Services, Inc.$753
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$7,5008%
  • Grants$64,82768%
  • Travel & lodging$11,84312%
  • Food & beverage$9,90710%
  • Education$1,0031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$95,080 in reported general payments places this provider in the 90th percentile of 42 clinical cardiac electrophysiology providers in Alabama.

See all clinical cardiac electrophysiology providers in Alabama

Medicare billing

Part B allowed, 2024
$237,775
Medicare patients
610
Services billed
3,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban340$293,752
MultaqDronedarone Hcl66$66,989
XareltoRivaroxaban64$55,979
EntrestoSacubitril/Valsartan19$15,078
Flecainide Acetate156$9,285
Amiodarone Hcl128$3,690
Metoprolol Succinate242$3,270
Diltiazem 24hr Er (Cd)Diltiazem Hcl48$943
Carvedilol88$883
Verapamil ErVerapamil Hcl28$840
Metoprolol Tartrate55$405
Atorvastatin Calcium19$378
Spironolactone11$225
Potassium Chloride11$175
Pantoprazole Sodium22$155

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$210$293,752340 claims
Sanofi-aventis U.S. LLCMultaq$17$66,98966 claims
Johnson & JohnsonXarelto$80$55,97964 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 42 clinical cardiac electrophysiology providers in Alabama.

Other clinical cardiac electrophysiology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →